跳至主要内容
临床试验/NCT04930666
NCT04930666已完成不适用

The Development and Pilot Testing of a Brief Shared Decision-Making Intervention to Improve Palliative Care Outcomes for Adults With Advanced Lung Disease

Columbia University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年11月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Number of qualitative interviews completed in the development phase

研究概览

简要总结

This study aims to:

  1. Develop the BREATHE-ALD intervention for adults with Advanced Lung Disease, multiple chronic conditions, and palliative care needs and their caregivers using interviews with 10 advanced lung disease (ALD) adults and their caregivers
  2. To evaluate the feasibility and acceptability of intervention procedures; and
  3. To explore intervention effects on ALD outcomes

详细描述

This study addresses the important problem of adults with symptomatic advanced lung disease (ALD) who are at high risk for poor outcomes. Palliative care (PCare) improves the quality of life of individuals and their caregivers through the prevention and relief of suffering by identifying, assessing and treating the physical, psychosocial and spiritual problems associated with life-threatening illness. However, pulmonary clinicians rarely refer adults with ALD to PCare because of time demands, a lack of confidence in PCare and the perceived threat PCare poses to the relationship they have established with the ALD adult. Therefore, we are developing BREATHE-ALD (BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease [ALD]), a novel shared decision-making (SDM) intervention to improve outcomes for adults with ALD.

The study includes two phases: (1) a development phase to develop BREATHE-ALD using interviews with 10 ALD adults and their caregivers with expert review to adapt BREATHE, and (2) a pilot validation phase conducting a pilot trial in which 10 adults with ALD receive BREATHE-ALD. We will follow adults with ALD for 3 months post-intervention to assess the impact of BREATHE-ALD on self-management and patient outcomes.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient participants with symptomatic advanced lung disease (ALD) followed at Weill Cornell Medicine (WCM).
  • Caregiver participants who care for adults with symptomatic ALD followed at Weill Cornell Medicine.

排除标准

  • Patients that have serious mental health conditions that preclude completion of study procedures or confound analyses.
  • Caregivers that have serious mental health conditions that preclude completion of study procedures or confound analyses.
  • Inclusion Criteria:
  • Patient participants with symptomatic advanced lung disease (ALD) followed at Weill Cornell Medicine (WCM).
  • Nurse practitioner must manage a panel of adult ALD patients.
  • Exclusion Criteria:
  • Patients that have serious mental health conditions that preclude completion of study procedures or confound analyses.
  • Patients anticipated to have less than 3-month survival.

结局指标

主要结局

Number of qualitative interviews completed in the development phase

时间窗: Up to 6 months

Qualitative interviews will be conducted with adults with advanced lung disease and their caregivers to understand their experiences managing ALD using semi-structured in-depth individual interviews. The information collected will aid the design of BREATHE-ALD and the implementation of the pilot phase of this study.

Ratio of participants who completed the intervention to the number of participants consented

时间窗: Up to 3 months post-intervention

To determine the level of retention, the ratio of participants who completed the intervention to the number of participants consented will be measured.

Mean mMRC (Modified Medical Research Council) Dyspnea Scale

时间窗: Up to 3 months post-intervention

The mMRC (Modified Medical Research Council) Dyspnea Scale measures the effect of breathlessness when performing daily activities. The mMRC breathlessness scale comprises five statements that describe almost the entire range of respiratory disability from none (Grade 1) to almost complete incapacity (Grade 5).

次要结局

  • Mean Short Form 36(Baseline, 1 month, 2 months, and 3 months (post-intervention))
  • Mean PROMIS Pain Intensity - Short Form V10 3a(Baseline, 1 month, 2 months, and 3 months (post-intervention))
  • Mean PROMIS Fatigue - Short Form 6a(Baseline, 1 month, 2 months, and 3 months (post-intervention))
  • Mean St. George's Respiratory Questionnaire(Baseline, 1 month, 2 months, and 3 months (post-intervention))
  • Mean Shared Decision Making Questionnaire(Baseline (immediately post-intervention))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maureen George

Professor of Nursing at CUIMC

Columbia University

研究点 (1)

Loading locations...

相似试验